Background/Aims: Vitamin A (VA) protects the intestinal epithelial barrier by improving cell migration and proliferation. Our previous studies demonstrated that VA deficiency (VAD) during pregnancy suppresses the systemic and mucosal immune responses in the intestines of offspring and that VA supplementation (VAS) during early life can increase immune cell counts. However, little is known about the mechanisms by which VA regulates intestinal epithelial barrier function. Methods: Caco-2 cells were treated with all-trans retinoic acid (ATRA) for 24 hours to determine the optimum ATRA concentration to which the cells in question respond. Caco-2 cells were infected with recombinant adenoviruses carrying retinoic acid receptor beta (Ad-RARβ) and small interfering RARβ(siRARβ) to assess the effects of RARβ signalling on the expression of specific proteins. A siTLR4 lentivirus was used to knockdown Toll-like receptor 4 (TLR4) in Caco-2 cells to determine its role in the protective effects of VA on the intestinal epithelial barrier, and experiments involving TLR4-knock-out mice were performed to verify the effect of TLR4. VA normal (VAN), VAD and VAS rat models were established to confirm that changes in RARβ, TLR4 and ZO-2 expression levels that occurred following decreases or increases in retinol concentrations in vivo, and the permeability of the Caco-2 cell monolayer, as well as that of the epithelial barrier of the rat intestine was detected by measuring transepithelial resistance (TER) or performing enzyme-linked immunosorbent assay (ELISA). Retinoic acid receptor (RAR), toll like receptor (TLR) and tight junction (TJ) mRNA and protein expression levels in Caco-2 cells and the colon monolayers in the rat and mouse models were measured by PCR and western blotting, respectively. Co-immunoprecipitation (co-IP) and immunofluorescence staining were performed to assess the interactions among RARβ, TLR4 and zonula occluden-2 (ZO-2) in Caco-2 cells, and chromatin immunoprecipitation (ChIP) assay was performed to assess the binding between RARβ and the TLR4 promoter sequence in Caco-2 cells. Results: In the present study, ATRA treatment not only increased the TER of the Caco-2 monolayer but also up-regulated the expression levels of RARβ, TLR4 and ZO-2 in Caco-2 cells. The expression levels of these three proteins were significantly decreased in the colonic epithelial monolayers of VAD rats compared with those of VAN rats and were significantly increased following VAS in the corresponding group compared with the control group. Furthermore, the above changes in TLR4 and ZO-2 expression levels were augmented or attenuated by Ad-RARβ or siRARβ infection, respectively, in Caco-2 cells. Interestingly, siTLR4 down-regulated ZO-2 expression but did not affect RARβ expression in Caco-2 cells, and in VAD mice the lack of TLR4 did not affect ZO-2 expression. We noted direct interactions between RARβ and TLR4, TLR4 and ZO-2 in Caco-2 cells, and ChIP assay showed that RARβ could bind to the TLR4 promoter but not the ZO-2 promoter in Caco-2 cells. Conclusion: Taken together, our results indicate that RARβ enhanced ZO-2 expression by regulating TLR4 to improve intestinal epithelial barrier function in Caco-2 cells, as well as in rat and mouse models, but not in humans.
Introduction
Vitamin A (VA) and its derivatives (i.e., retinol, retinal, and retinoic acid) play important roles in many general biological processes, such as cell proliferation, differentiation and apoptosis, and the immune response and vision [1] [2] [3] . Retinoic acid (RA) also plays a role in protecting the intestinal barrier, and cellular RA bioavailability has been shown to determine epithelial integrity [4] . Additionally, VA improves intestinal epithelial cell migration and proliferation and prevents Clostridium difficile toxin A challenge-induced reductions in transepithelial resistance (TER) [5] . Our previous studies showed that VA deficiency (VAD) during pregnancy suppresses the systemic and mucosal immune responses in the intestines of offspring by decreasing lymphocyte counts [6] . Moreover, VA supplementation (VAS) during early life can improve immune cell counts to enhance the intestinal immune responses of rats [7] . Additionally, VA can regulate intestinal mucosal immunity and homeostasis [8] and can also improve intestinal barrier function [9] . The results of a previous metaanalysis suggested that VA treatment decreased the incidence of and the risk of mortality from diarrhoea in children in developing countries [10] . VA also plays an important role in epithelial function; however, how VA regulates intestinal barrier function, as well as which RA receptors (RARs) regulate the protective effects of VA on the intestinal epithelial cell monolayer, remains unknown.
Toll-like receptors (TLRs), which have been linked to innate and adaptive immunity, can trigger intestinal epithelial cell proliferation when the intestinal barrier is damaged [11] . As the major receptor associated with lipopolysaccharide activation, TLR4, along with other TLRs, maintains mucosal homeostasis in the intestine. TLR4/MD-2 expression is upregulated in inflammatory bowel disease (IBD) [12, 13] , and TLR4 and MyD88 signalling are required to optimize cell proliferation and protect against apoptosis in intestinal injury [14, 15] . Tight junctions (TJs) are the apical-most intercellular epithelial cell structures and contain many proteins, such as occludins, zonula occludens (ZOs) and actin [16, 17] . TJs maintain intestinal epithelial barrier integrity, and their destruction results in disruption of the intestinal environment. ZO proteins are cytosolic scaffolds that anchor peripherally located transmembrane proteins to the actin cytoskeleton, and their absence completely abrogates TJ assembly and paracellular regulation [18, 19] . Therefore, ZO proteins are crucial for both barrier integrity and TJ formation. TLRs exert critical protective effects on TJs through a variety of pathways. For example, TLR2 enhances ZO-1-mediated intestinal epithelial barrier integrity via protein kinase C [20] , and polyamine-induced TLR2 expression enhances epithelial barrier function [21] . Interestingly, VAD interferes with gastrointestinal mucosal barrier integrity by altering bacterial populations and innate immunity-related gene expression, and modulating TLR2 expression [8] . However, the data substantiating the idea that VA can regulate TJ proteins through TLRs in the intestinal epithelium are limited.
To address these issues, we focused on VA and the mechanisms by which it regulates colonic innate barrier function through the RAR pathway. First, we determined the optimum concentration of RA to which the Caco-2 cell line, a human colon carcinoma cell line that simulates the intestinal epithelial monolayer [22] , responds to identify the proteins targeted by RA to regulate barrier function. Second, we established rat models of VAD and VAS to confirm that changes in RARβ, TLR4 and ZO-2 expression levels occur following decreases or increases in retinol concentration in vivo. VA normal (VAN) rats served as controls. Third, we altered RARβ signalling in Caco-2 cells to determine the regulatory effects of RARβ on TLR4 and ZO-2 expression levels. Fourth, we used a siTLR4 lentivirus and TLR4 knockout mice to determine whether TLR4 is necessary for the protective effects of VA on the intestinal epithelium in vitro and in vivo. Finally, we assessed the interactions among the three proteins mentioned above using immunoprecipitation.
Materials and Methods

Cell culture
Caco-2 cells were obtained from the Shanghai Institute for Biological Sciences, Chinese Academy of Science (Shanghai, China). Caco-2 cells (1×10 5 cells/cm 2 ) were incubated with Dulbecco's modified Eagle medium (DMEM) containing 10% foetal bovine serum (FBS) in a 5% CO 2 humidified incubator at 37 °C. The Caco-2 cells were washout after 3 h seeding, and they were confluent after 2-3 days. The Caco-2 cells were differentiated following 8 days of confluency, and then the experiments were carried out. The cells were treated with all-trans retinoic acid (ATRA) (R2625, Sigma-Aldrich, St. Louis, MO) at five different concentrations (0.5 μmol/L, 1 μmol/L, 5 μmol/L, 10 μmol/L, and 20 μmol/L) for 24 hours after reaching confluence. Untreated cells served as controls. The cells were infected with recombinant adenoviruses carrying RARβ (Ad-RARβ) and a small-interfering RNA targeting RARβ (siRARβ) for 48 hours, as described previously [23] . An adenovirus containing red fluorescent protein (Ad-RFP) was used as a control. All three viruses were utilized under similar interference conditions. A rat siTLR4 lentivirus containing RFP was used to knockdown TLR4 in Caco-2 cells for 48 hours, and a lentivirus containing RFP served as a control. These viruses were utilized under similar interference conditions. The sequences of the siRARβ, RFP, siTLR4, and RFP constructs are listed in Table 1 . Each group of cells was treated at the same stage.
Animals
The animal experiments were approved by the Animal Experimentation Ethics Committee of Chongqing Medical University (Chongqing, China) and were conducted in accordance with the guidelines of the Animal Care Committee of Chongqing Medical University. All the animals were housed under specific pathogen-free (SPF) laboratory conditions. Sprague Dawley (SD) rats were purchased from the Center of Zoology of Chongqing Medical University [certificate: SCXK (Yu) 2007-0001, Chongqing, China], and TLR4 Table 1 . Sequences of the interfering RNAs /-and wild-type(WT) mice derived from Jackson laboratories (Maine, USA) were purchased from the Model Animal Research Center of Nanjing University (MARC). The VAN and VAD animal models were constructed according to the methods described previously [7, 24, 25] . Maternal VAD rats were fed a VAD-inducing diet comprising 400 IU/kg VA for 4 weeks to establish the VAD animal model before gestation, whereas VAN rats received a VAN diet containing 6,500 IU/kg VA to serve as a control group. When serum retinol levels, which were measured using blood samples taken from the tails of the maternal VAD rats, decreased to 1.05 μmol/L, the maternal VAD rats were mated with normal male rats. Pregnant maternal rats were fed either the VAD diet or the VAN diet during both gestation and lactation to maintain stable serum retinol levels. After weaning, the pups from the VAD group were randomly assigned to the VAD and VAS groups. The pups in the VAD group were subsequently fed the VAD diet continuously for 6 weeks, while the pups in the VAN group were fed the VAN diet continuously for the same time period. The VAS group was subjected to the following treatments: lactating maternal VAD rats were fed the VAN diet until the weaning period, and the pups of gestational VAD rats were intragastrically administered 50 IU of VA daily for 7 days and fed the VAN diet for 6 weeks after weaning.
Serum retinol detection
Serum retinol concentrations were determined by high performance liquid chromatography (HPLC), according to a method described previously [24] . Briefly, 200 μL of serum was deproteinized with dehydrated alcohol, and then the retinol was extracted with hexane and evaporated with nitrogen gas. The residue was dissolved in 100 μL of the indicated mobile phase mixture (methanol:water ratio of 97:3), after which the entire sample was transferred to a bottle incorporated into the HPLC apparatus (DGU-20 As, Shimadzu Corporation, Kyoto, Japan). The retinoids were separated by chromatography on an analytical column (Hypersil phenyl 120 A 5 mm, 250×4.6 mm, Phenomenex, USA) via gradient elution of the mobile phase in a liquid chromatograph equipped with a 315-nm ultraviolet photodiode array detector.
Enzyme-linked immunosorbent assay (ELISA)
The levels of zonulin release in the culture media of the different treatment groups were measured by a human zonulin ELISA kit (Hermes Criterion Biotechnology), according to the manufacturer's instructions. Background values, which served as control values, were also analysed. The absorbance was measured at a wavelength of 450 nm, and the optical density values were calculated based on standard curves constructed for each of the assays, which were performed in triplicate.
TER
Caco-2 cells were seeded (1×10 5 cells/cm 2 ) in a transwell chamber with 0.4-μm pores (PIHT 12R48, Merk Millipore) that had been placed in a 24-well plate. The other two transwells remained blank. After being confluent, cells were differentiated and polarized for 14 days in the culture medium with or without ATRA treatment. The TER of the monolayer was measured with a Millicell Electrical Resistance System-2 (Merk Millipore), according to the manufacturer's protocol [26] . We corrected the TER values by subtracting the background resistance of the blank membranes and then multiplied the values by the area of the transwell. Three independent experiments were performed.
The TER of the intestinal epithelial barrier was determined with an Ussing Chamber and Voltage/ Current ClampSystem (Physiology Instruments, SanDiego, USA). After being stripped from the muscular layer using an anatomical microscope, the colon mucosal tissue layer was fixed on the Ussing Chamber and bathed on both its serosal and mucosal sides with Krebs-Ringer solution. The bathing solutions were oxygenated (95% O 2 /5% CO 2 ) and circulated in water-jacketed reservoirs at 37 °C [27] . After equilibrating in the Ussing chambers for 20 minutes, the cells were subjected to the experiments for up to 1.5 hours. TER was calculated using the data from the different short-circuit currents. Data acquisition and analysis were performed using Acquire & Analyse software.
RNA extraction and real-time polymerase chain reaction (PCR)
Total RNA from the animal colonic mucosal layer cells and Caco-2 cells was isolated and purified using an RNA extraction kit (RP1202, BioTeke, Beijing, China). The mRNA was then reverse transcribed into first-strand cDNA using a PrimeScript RT Reagent Kit (DRR036A, Takara Bio, Inc.). Real-time PCR reactions were performed using a Real Master Mix Kit (RR820A, Takara Bio, Inc.) and a real-time PCR instrument (CFX Connect Real-Time System, Bio-Rad). Each sample was quantified in triplicate. Gene expression levels were normalized to β-actin expression levels in the same samples and were calculated using CFX Manager Software. Three independent experiments were performed, and each experiment was performed in duplicate. The sequences of the primers specific for RARα, RARβ, RARγ, TLR2, TLR4, occludin, ZO-1, ZO-2 and β-actin in the corresponding species were designed using Primer Premier 5 software and are listed in Tables 2 and 3 . 
Western blotting
Total proteins were extracted from the animal colonic epithelial cell monolayer and Caco-2 cells using a specific extraction kit (PP1901, BioTeke), and the protein concentrations in the homogenates were determined with a Micro BCA Protein Assay Kit (P1001, BioTeke) using an enzyme-labelling instrument (Thermo Scientific Varioskan Flash). Approximately 30 μg total protein per lane was loaded onto a 10% SDS-polyacrylamide gel (Beyotime, Haimen, China) for electrophoretic separation, after which the proteins were transferred to polyvinylidene fluoride membranes (HATF00010, Merk Millipore), which were blocked with 5% bovine serum albumin (BSA) in TBS containing 0.5% Tween for 1 h at 37 °C and then probed with anti-RARβ (ab53161, Abcam), anti-TLR4 (ab22048, Abcam), anti-ZO-2 (2847, Cell Signaling Technology) or anti-β-actin (sc-47778, Santa) primary antibodies over night at 4 °C. The proteins were subsequently probed with HRP-conjugated secondary antibodies (Santa Cruz Biotechnology) for 1 hour at room temperature and visualized on an ECL Imaging System (SynGene GBOX) using a chemiluminescence kit (1229601, Merk Millipore). Three independent experiments were performed.
Co-immunoprecipitation
The total protein extracts from the Caco-2 cell line were prepared using the appropriate kits (PP1801, BioTeke), and the protein concentrations were determined as described above. For immunoprecipitation analysis, 300 μg of total protein extract was incubated with 0.2-2 μg of anti-RARβ (sc-552G, Santa), anti-ZO-2 (sc-8148, Santa) or control IgG antibodies and protein-G agarose beads (Beyotime) overnight at 4 °C. After being washed three times, the immunoprecipitates were boiled and then assessed by western blotting. Three independent experiments were performed.
Immunofluorescence staining Confluent Caco-2 cells were cultured on 1×1-cm cover slips, fixed with a mixture of methanol and glacial acetic acid (ratio of 3:1) for 20 minutes at 4 °C and then washed three times with phosphate-buffered saline (PBS). The fixed cells were subsequently incubated in PBS containing 0.2% Triton X-100 and blocked with 5% BSA for 1 hour at room temperature. The cells were then incubated with anti-RARβ (ab53161, Abcam), Table 2 . Sequences of the primers specific for the human or mouse genes Table 3 . Sequences of the primers specific for the rat genes Table 4 . Sequences of the primers specific for the promoters anti-TLR4 (sc-13593, Santa) or anti-ZO-2 (sc-8148, Santa) antibodies overnight at 4 °C. The cells were subsequently washed and incubated with anti-rabbit IgG, anti-mouse IgG or anti-goat IgG (Invitrogen) for 1 hour, after which the nuclei were stained with 4′, 6-diamidino-2-phenylindole (DAPI; Sigma) for 10 minutes at room temperature in a dark room. Fluorescence images were captured with an immunofluorescence laser confocal microscope (Nikon). Control IgGs were used as negative controls. Three independent experiments were performed.
Chromatin immunoprecipitation (ChIP)
Samples were prepared using a ChIP kit (17-371, Merk Millipore), according to the manufacturer's protocols. Caco-2 cells were treated with 1% formaldehyde to crosslink the proteins of interest to the DNA sequences of interest. The cells were prepared with SDS lysis buffer and then sonicated with a Bioruptor UCD-200 (Diagenode), after which the DNA was sheared into 200-1,000-bp fragments. Equal amounts (100 μl) of DNA/protein complex were assayed and diluted to the indicated volume (900 μl) with ChIP dilution buffer. Before IP, 10 μl of supernatant from each sample was designated as the 'total input chromatin', and the remaining supernatant was incubated with 1-10 μg of primary antibodies against RARβ (sc-552X, Santa) or negative control IgG antibodies overnight at 4 °C. DNA reverse-crosslinking and purification were performed according to the manufacturer's protocols, and semiquantitative PCR amplification was performed as described in the real-time PCR section. The primers used for promoter amplification are listed in Table 4 .
Statistical analysis
All the data are expressed as the mean±SEM. The differences between groups were analysed with one-way analysis of variance (ANOVA) and t-tests using GraphPad Prism software, version 5.0. P<0.05 was considered statistically significant.
Results
RA enhanced the Caco-2 cell monolayer
The usefulness of the Caco-2 cell line in vitro models of intestinal epithelial permeability has been established previously. The above cells were treated with ATRA(a major active cellular retinoid metabolite) at five different concentrations (0.5 μmol/L, 1 μmol/L, 5 μmol/L, 10 μmol/L, and 20 μmol/L) for 24 hours (Steffen Baltes), after which they were examined under a microscope and found to be more tightly arranged as a monolayer than untreated cells. As shown in Fig. 1A , ATRA-treated cells were closer to one another than untreated cells, and the junctions between them were brighter and thicker than those between untreated cells. The TER of the Caco-2 cell monolayer was subsequently detected with a digital voltageresistance metre. TER is a sensitive indicator of and is inversely proportional to epithelial barrier permeability [28] . The TER of the Caco-2 cell monolayer was 275.1±14.69 Ω. cm 2 in the group of cells treated with 5 μmol/L ATRA, a value that was 2.13 times greater (P=0.0003, t test) than that in the untreated control group (128.8±12.75 Ω.cm 2 ; Fig. 1B ). Zonulin is a physiologic regulatory protein that reflects intestinal permeability [29] . Alessio Fasano and his colleagues [7] found that small intestines exposed to enteric bacteria secreted zonulin, which resulted in increases in intestinal permeability. The relationship between zonulin secretion and intestinal permeability is direct; thus, the higher the level of zonulin secreted, the larger the increase in intestinal permeability. As shown in Fig. 1C , the zonulin concentration (3.164±0.7723 ng/mL) in the Caco-2 culture medium of the ATRA (5 μmol/L) group was significantly lower (P=0.01, t test) than that in culture medium of the control group (9.506±1.481 ng/mL). These data demonstrate that ATRA treatment enhances Caco-2 cells to maintain a tight barrier, thereby decreasing barrier permeability.
ATRA induced RARβ, TLR4 and ZO-2 expression in Caco-2 cells
RA plays an essential role in biological processes by binding to its receptors, namely, RARα, RARβ and RARγ. ATRA exerts its biological effects at physiological doses. In the current study, to better understand the regulatory mechanism through which ATRA exerts its effects, we administered ATRA at 'pharmacological' concentrations as a treatment. We analysed RARs mRNA expression levels in cells treated with different concentrations of ATRA for 24 hours by qPCR. We found that RARβ mRNA levels but not RARα and RARγ levels increased in ATRA-treated cells compared with control cells (data not shown). Fig. 2A shows that RARβ expression levels were low without ATRA treatment; however, treatment with 0.5-20 μmol/L ATRA significantly up-regulated RARβ expression levels (P<0.0001, ANOVA), which peaked in response to treatment with 1 μmol/L ATRA and then decreased in response to treatment with high concentrations of ATRA (20 μmol/L), indicating that high pharmacological concentrations of ATRA may be toxic to Caco-2 cells. Taken together, these results suggest that the RARβ pathway may be regulated by ATRA in Caco-2 cells.
TLRs are expressed in a variety of cells and link innate and acquired immunity. TLR2 and TLR4 are expressed in human colon tissues; however, the expression levels of these proteins are very low in human colon tissues [12, 30, 31] . Caco-2 cells are a human colon intestinal epithelial cell line in which multiple TLRs can be detected. In the present study, we analysed TLR2 and TLR4 mRNA expression levels by qPCR, and found that TLR4 expression levels were increased (P<0.0001, ANOVA) by treatment with ATRA for 24 hours compared with no treatment and peaked in response to treatment with 5 μmol/L ATRA (Fig. 2B) . However, we noted no significant differences in TLR2 mRNA expression levels between treated and untreated cells (data not shown). These data indicate that the TLR4 pathway may be related to the RA pathway in Caco-2 cells. As shown in Fig. 2C , ZO-2 mRNA expression levels were significantly increased (P=0.0001, ANOVA) in cells treated with ATRA for 24 hours compared with untreated cells, while occludin and ZO-1 mRNA expression levels in ATRA-treated cells were not significantly different compared from those in control cells (data not shown). We also found that RARβ, TLR4 and ZO-2 protein expression levels were enhanced by treatment with ATRA at different concentrations compared with no treatment (Fig. 2D) , results consistent with those of the experiments in which the mRNA expression levels of the indicated proteins were determined. The above results suggest that the TLR4 and ZO-2 proteins may help ATRA induce Caco-2 cell rearrangements via the RARβ pathway.
VAD decreased TER and RARβ, TLR4, and ZO-2 expression levels in rat colon mucosal cell layers
To evaluate the effects of VA on intestinal epithelial barrier function, we established VAD and VAS rat models in the current study. Fig. 3A shows that serum retinol levels in sixweek-old VAD rats were significantly lower (n VAD = 14, n VAN = 14, P<0.0001, t test) than those in VAN rats of the same age, suggesting that the VAD rat model was successfully established. Serum retinol levels increased significantly in VAD pups that received VA supplementation beginning on postnatal day 1 compared with VAD pups that did not receiving supplementation (n VAS = 10, n VAD = 14, P<0.0001, t test). Additionally, we noted no significant difference (P=0.3564, t test) in serum retinol levels between the VAN and VAS groups. The serum VA levels of six-week-old rats in the VAN(n VAN =14), VAD (n VAD =14) and VAS (n VAS =10) groups were tested by HPLC. ***P<0.001. (B) A Ussing chamber was used to measure the differences in TER among the VAN (n VAN =9), VAD (n VAD =11) and VAS (n VAS =6) groups. *P<0.05, **P<0.01, ***P<0.001. (C) The mRNA expression levels of RARβ, TLR4 and ZO-2 in the colon monolayers of the VAN (n VAN =5), VAD (n VAD =5), and VAS (n VAS =4) groups. *P<0.05, **P<0.01, ***P<0.001. (D) RARβ, TLR4 and ZO-2 protein expression levels were detected in the colons of the VAN (n VAN =5), VAD (n VAD =5) and VAS (n VAS =4) groups. The data are representative of three independent experiments. ) was significantly higher (n VAS =6, P=0.0050, t test) than that in the VAD group but was still decreased compared with that in the VAN group (P=0.019, t test; Fig. 3B ).
Moreover, we also assessed the changes in RARβ, TLR4 and ZO-2 mRNA and protein expression in the rat colonic monolayer. The results showed (Fig. 3C) that RARβ, TLR4 and ZO-2 mRNA expression levels were significantly reduced (n VAD =5, n VAN =5, P RARβ =0.0138, P TLR4 =0.0206, P ZO-2 =0.0250, t test) in the colon cell monolayer of the VAD group compared with that in the VAN group, while the expression levels of the three genes were significantly increased (n VAD =5, n VAS =4, P RARβ =0.0008, P TLR4 =0.0078, P ZO-2 =0.0199, t test) in the VAS group compared with the VAD group. The trends in RARβ, TLR4 and ZO-2 protein expression were consistent with those in RARβ, TLR4 and ZO-2 mRNA expression (Fig. 3D ). These results demonstrate that VA deficiency can decrease barrier function and RARβ, TLR4 and ZO-2 expression levels in the colonic cell monolayer and that timely VA intervention can effectively enhance RARβ, TLR4 and ZO-2 expression levels to improve intestinal barrier function. 
TLR4 and ZO-2 expression levels were regulated by Ad-RARβ or siRARβ in Caco-2 cells
To determine whether TLR4 or ZO-2 expression levels were regulated by the RARβ pathway, we altered RARβ signalling in Caco-2 cells using recombinant RARβ or siRARβ adenoviruses. First, we infected the cells with Ad-RARβ and Ad-RFP. We found that RARβ mRNA expression levels were significantly elevated (P=0.0017, t test) in Caco-2 cells infected with Ad-RARβ compared with cells infected with Ad-RFP (Fig. 4A) and that both TLR4 and ZO-2 mRNA expression levels were increased (P TLR4 <0.0001, P ZO-2 <0.0001, t test) in the former group of cells compared with the latter group of cells ( Fig. 4B and 4C ). After Ad-RARβ infection, RARβ, TLR4 and ZO-2 protein expression levels were also enhanced in the indicated group compared with the RFP group (Fig. 4D ). These data demonstrate that the effects of RARβ over-expression on Caco-2 cells were consistent with those of ATRA treatment.
Second, we used siRARβ adenoviruses to infect Caco-2 cells. When siRARβ knocked down RARβ expression, as shown in Fig. 4E , TLR4 and ZO-2 protein expression levels were also suppressed in the corresponding group of Caco-2 cells compared with the RFP-treated group of cells. Finally, we treated Caco-2 cells with the combination of siRARβ adenoviruses and ATRA, and found that both TLR4 and ZO-2 expression levels decreased in the indicated group compared with the ATRA+RFP group following the decrease in RARβ expression levels (Fig. 4F) . The above results show that ATRA regulates TLR4 and ZO-2 expression levels to enhance colon epithelial barrier function through the RARβ pathway.
siTLR4 down-regulated ZO-2 expression levels but did not affect RARβ expression levels in Caco-2 cells
We also hypothesized that TLR4 participates in the pathway modulated by RARβ. To confirm this hypothesis, we reduced TLR4 expression levels using a lentivirus containing TLR4-silencer sequences. As shown in Fig. 5A , the changes in TLR4 expression in the GFP and siTLR4 groups were consistent with the changes in ZO-2 expression but not RARβ expression in the indicated groups (Fig. 5A) . RARβ protein expression levels increased after ATRA treatment; however, siTLR4 still reduced ZO-2 expression levels (Fig. 5B ). These data demonstrate that TLR4 likely serves as an intermediary in the process by which RARβ regulates ZO-2 expression in Caco-2 cells. Cell
TLR4 was required for the protective effects of RARβ on the intestinal epithelial barrier in mice
We used a TLR4 -/-mouse model to determine whether TLR4 participates in the mechanism by which VA maintains intestinal epithelial barrier function. We established VAN and VAD models in both WT(WTVAN and WTVAD) and TLR4 -/-mice (KOVAN and KOVAD). Fig. 6A shows that serum retinol levels in six-week-old WT and TLR4
-/-mice with VA deficiency were lower than those in VAN mice of the same age (n WTVAN =9, n WTVAD =7, n KOVAN =9, n KOVAD =11), suggesting that the VAD model was successfully established in both WT and TLR4 -/-mice. The trends in TER noted in the WTVAN and WTVAD mouse models were similar to those noted in the VAN and VAD rat models. However, colonic TER levels were not different between the TLR4 -/-VAN and VAD mouse groups (n KOVAN =9, n KOVAD =11, P=0.8234, t test; Fig. 6B) .
RARβ, TLR4 and ZO-2 mRNA expressions levels were also significantly reduced (n WTVAD =5, n WTVAN =5, P RARβ =0.0103, P TLR4 =0.0030, P ZO-2 <0.0001, t test; Fig. 6C ) in the colonic Fig. 6 . The differences in serum retinol levels, TER, and RARβ, TLR4 and ZO-2 expression levels in the colon monolayers of WT or TLR4 -/-mice between the VAN and VAD groups. WT-VAN refers to WT mice with normal VA levels, WTVAD refers to WT mice with VA deficiency, KOVAN refers to TLR4 KO mice with normal VA levels, and KOVAD refers to KO mice with VA deficiency. (A) Serum retinol levels in six week-old mice in the WT-VAN (n WTVAN =9), WTVAD (n WT-VAD =7), KOVAN (n KOVAN =9) and KOVAD (n KOVAD =11), groups were determined by HPLC. **P<0.01, ***P<0.001. (B) A Ussing chamber was used to measure the differences in TER among the four groups (n WTVAN =9, n WTVAD =7, n KOVAN =9, n KOVAD =11). **P<0.01. (C-D) RARβ, TLR4 and ZO-2 mRNA expression levels were reduced in the colon monolayers of WTVAN, WTVAD, KO-VAN, and KOVAD mice (n=5 mice per group). *P<0.05, **P<0.01, ***P<0.001. (E) RARβ, TLR4 and ZO-2 protein expression levels were detected in WT and KO mice with different serum retinol levels (n=5 mice per group).
monolayers of WTVAD mice compared with those of WTVAN mice. However, in the KO groups, only RARβ mRNA expression levels were lower in KOVAD mice than in KOVAN mice, while TLR4 expression was not detected in either group, and ZO-2 expression levels were not different between the two groups (n KOVAD =5, n KOVAN =5, P RARβ <0.0001, P ZO-2 =0.1919, t test; Fig.  6D ). Fig. 6E shows that the expression levels of the three proteins were significantly reduced in WTVAD mice compared with WTVAN mice; however, ZO-2 protein expression levels were not different between the KOVAN and KOVAD groups, while RARβ protein expression levels were significantly decreased in KOVAD mice compared with KOVAN mice. These results demonstrate that TLR4 is an important component of the RARβ pathway that regulates ZO-2 expression to protect the epithelial barrier.
RARβ bound with TLR4 to increase ZO-2 expression levels
To identify the interactions among RARβ, TLR4 and ZO-2, we performed coimmunoprecipitation (Co-IP) and ChIP assays involving Caco-2 cells treated with 5 μmol/L ATRA. Co-IP, which is based on specific antibody and antigen combinations, can determine whether proteins interact under physiological conditions. We used an anti-RARβ antibody to precipitate the TLR4 or ZO-2 protein, and as shown in Fig. 7A , RARβ bound to the TLR4 protein but did not bind to the ZO-2 protein in Caco-2 cells treated with or without ATRA. Similarly, the ZO-2 protein interacted with TLR4 but not RARβ in Caco-2 cells treated with or without ATRA (Fig. 7B) . Moreover, using laser-scanning confocal microscopy, we determined that RARβ and TLR4 co-localized near the nucleus and on the membranes of Caco-2 cells. The TLR4 and ZO-2 proteins were co-expressed on the cell membrane; however, the RARβ and ZO-2 proteins did not appear to be co-expressed in Caco-2 cells treated with or without ATRA (Fig. 7C) . Therefore, the interactions among the three proteins that were detected by co-IP were consistent with those observated via confocal microscopy.
ChIP-qPCR is a technique used to study interactions between DNA and proteins. To investigate the mechanism by which RARβ regulates TLR4 expression in Caco-2 cells following ATRA treatment, we performed ChIP assay. As shown in Fig. 8B , RARβ was enriched (A) RARβ could interact with TLR4 but not ZO-2 in Caco-2 cells, as determined by co-IP using RARβ antibodies. (B) ZO-2 bound to TLR4 in Caco-2 cells; however, ZO-2 did not interact with RARβ, as determined by co-IP using ZO-2 antibodies. (C) Laser scanning confocal microscopy detected the subcellular distributions of the three proteins in cells treated with or without ATRA using immunofluorescence. The red colour refers to RARβ, the green colour refers to TLR4, the purple colour refers to ZO-2, and DAPI stained the nuclei of the Caco-2 cells. RARβ, TLR4 and ZO-2 were co-localized(original magnification ×600). Three independent experiments were performed. in the TLR4 promoter sequence but not the ZO-2 promoter sequence in Caco-2 cells (Fig. 8C) . Taken together, these findings indicate that RARβ induced ZO-2 expression by binding to the proximal TLR4 promoter.
Discussion
The current study addressed whether VAS can rescue gestational VAD-induced colonic epithelial barrier dysfunction and the possible mechanism(s) by which this process occurs. The primary finding of this study was as follows: RA treatment triggered RARβ signalling pathway-mediated increases in TLR4 expression levels in the intestinal epithelium to facilitate ZO-2 expression to ameliorate colonic barrier function.
Numerous studies have shown that VA can improve intestinal epithelial integrity when diarrhoea and colitis damage the intestinal epithelium. The protective effects of VA manifest as increases in TER, reductions in intestinal permeability, and improvements in TJ complex expression [32] . Both TER and zonulin are indices of epithelial barrier permeability [28, 29, 33] . TER is directly proportional to intestinal epithelial integrity, and increases in zonulin secretion are followed by corresponding increases in intestinal permeability. Thus, the higher the level of zonulin release, the greater the increase in intestinal permeability. In the present study, we confirmed that RA, a metabolic and functional product of VA in vivo, has protective effects on intestinal epithelial barrier function. When RA increased the TER of the Caco-2 cell monolayer in the current study, intestinal permeability was decreased, and zonulin secretion was reduced. TER was also lower in the colonic epithelial monolayer of VAD rats than in the colonic epithelial monolayer of VAN rats; however, VAS effectively attenuated the intestinal barrier dysfunction caused by gestational VAD. These findings are consistent with the results of a study showing that the incidence of diarrhoea in children was decreased by oral VA administration [9] .
TJs play an essential role in maintaining intestinal epithelial integrity. Increasing numbers of studies have determined that VA plays a role in preserving intestinal epithelial structure; however, few in-depth studies on the molecular mechanisms by which VA preserves intestinal epithelial structure have been reported. Occludins, claudins and ZO proteins, which regulate epithelial proliferation, differentiation and permeability, are the major components of TJs [4, 16, 34] . RA enhances occludin, claudin, and ZO-1 expression [4, 32] . Our current data showed that ATRA treatment increased ZO-2 expression levels in Caco-2 cells. Furthermore, ZO-2 expression levels were reduced or enhanced in the colonic epithelial tissues of VAD or VAS rats, respectively, demonstrating that VA levels impact TJs in the colonic epithelium.
TLRs recognize intestinal bacteria to maintain mucosal homeostasis. When mucosal homeostasis is disrupted, PKC signalling participates in TLR-induced downstream events [20, 35, 36] . Cario et al suggested that TLR2 activation enhances ZO-1 via PKC, and Gibson et al reported that TLR2 plays a critical role in maintaining intestinal mucosal integrity during infections by bacterial pathogens. TLR2 can prevent epithelial cell apoptosis and maintain ZO-1 localization and functionality in the TJ complex [37] . ZO-1 and ZO-2 have similar structures, as ZO proteins exhibit considerable functional redundancy [38] [39] [40] . Our current study showed that TLR4 knockdown in vitro or knockout in vivo induced different changes in ZO-2 expression When TLR4 was knocked down via Ad-siTLR4 infection in Caco-2 cells, ZO-2 expression levels also decreased. However, when TLR4 was knocked out in mice, ZO-2 expression levels did not differ between the VAD and VAN groups. We subsequently confirmed that TLR4 interacted with ZO-2 following ATRA treatment in Caco-2 cells using Co-IP. However, whether TLR4 regulates ZO-2 via PKC signalling will be explored in future studies.
VA can regulate TLRs during the immune response. Blomhoff's group discovered that RA can improve critical immune parameters in CVID-derived B cells stimulated by TLR9 and RP105, findings that support the idea that RA can be combined with TLR stimulation to treat CVID [41, 42] . Eduardo showed that RA-mediated regulation of dendritic cell gastrointestinal activity required MyD88, which is associated with TLR, interleukin (IL)-1, and IL-18 signalling [43] . The present study of the effects of VA on intestinal epithelial integrity revealed that a relationship exists between VA levels and TLRs. We found that VA regulated TLR4 expression levels in the intestinal epithelium both in vivo and in vitro. These findings indicate that VA modulates the immune system.
The primary known function of RA is to regulate gene transcription through nuclear receptors, namely, RARs and retinoic X receptors (RXRs). The RAR family comprises the following three members: RARα, RARβ and RARγ [44] . Osanai et al reported that RARα stimulation attenuated epithelial barrier loss in experimental colitis. RA increases E-cadherin and ZO-1 expression levels through RARβ in the brain endothelial barrier [45] . We performed experiments demonstrating that ATRA increased RARβ expression levels in Caco-2 cells, results consistent with those of the experiments assessing RARβ expression in the colonic epithelial cell monolayer following VA supplementation to the VAD rats. TLR4 and ZO-2 expression levels increased with increasing RARβ expression levels in both Caco-2 cells and the colonic epithelial cell monolayer. However, TLR4 knockdown in Caco-2 cells did not change RARβ expression levels but decreased ZO-2 levels. These findings suggest that RARβ may be a key facilitator of improvements in intestinal barrier function following ATRA treatment.
Regardless of whether RARβ signalling increased or decreased, the changes in TLR4 and ZO-2 expression levels were consistent with those in RARβ expression in Caco-2 cells. Therefore, we speculate that RARβ regulated TLR4 and ZO-2 to maintain intestinal epithelial integrity. To better understand some of the potential effects of RARβ on barrier function, we studied the molecular interactions among these three proteins. The co-IP results, which are shown in Fig. 7A , demonstrated that RARβ interacted with TLR4, suggesting that RARβ can directly or indirectly combine with TLR4 and that TLR4 interacted with ZO-2; however, RARβ did not interact with ZO-2. Moreover, immunofluorescence staining showed that RARβ and TLR4 co-localized in the cytoplasm and nucleus and that TLR4 and ZO-2 co-localized on the membranes of Caco-2 cells. These phenomena were enhanced following ATRA treatment. However, RARβ rarely co-localized with ZO-2. Furthermore, we verified that the RARβ could bind to the promoter sequence of TLR4 but not that of ZO-2 in Caco-2 cells by ChIP assay. These results demonstrate that RARβ enhances ZO-2 expression by binding the TLR4 promoter sequence to regulate TLR4 mRNA transcriptional activity, i.e., the RARβ protein combines with the TLR4 promoter DNA sequence. Intriguingly, our finding that ZO-2 expression levels were not affected by decreases in RARβ expression levels in KOVAD mice strongly suggests that RARβ regulates TLR4 to enhance ZO-2 expression in the colon, most likely through two possible mechanisms. Specifically, our co-IP and immunofluorescence
